MRC1 and cancer: Multiple MMR-deficient cancers demonstrating the same pattern of MMR protein loss or with the same somatic MMR mutation would be an important “red flag” for postzygotic mosaicism testing, whereas age at cancer diagnosis appears to be less of an indicator in the few cases identified to date.